Stocklytics Platform
Asset logo for symbol OPTN
Optinose
OPTN68
$0.42arrow_drop_up1.56%$0.00
Penny Stock
Asset logo for symbol OPTN
OPTN68

$0.42

arrow_drop_up1.56%

Performance History

Chart placeholder
Key Stats
Open$0.41
Prev. Close$0.42
EPS-0.29
DividendNon-Dividend
Next Earnings Date-
Dividend Yield %-
Market Cap$63.36M
PE Ratio-
LOWHIGH
Day Range0.40
0.47
52 Week Range0.30
2.10
Ratios
Revenue-
EPS-0.29

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

About Optinose (OPTN)

Optinose Inc (OPTN) is a pharmaceutical company that specializes in the development and commercialization of innovative products for the treatment of various medical conditions. The company's flagship product is XHANCE, a nasal spray that delivers a unique formulation of medication to the nasal passages. XHANCE is indicated for the treatment of nasal polyps in adults, a condition that affects millions of people worldwide. By targeting the source of the inflammation and providing sustained drug delivery, XHANCE offers a novel option for patients with this chronic condition.
The stock price history of Optinose Inc (OPTN) has shown both volatility and growth potential. Since its initial public offering in 2017, the stock has experienced fluctuations in price, reflecting market sentiment and investor confidence. Despite these fluctuations, the overall trend has been positive, with the stock price increasing over time. This trend can be attributed to several factors, including the company's strong pipeline of products, strategic partnerships, and positive clinical trial results.
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
CEO
Dr. Ramy A. Mahmoud M.D., M.P.H.
Headquarters
Yardley
Employees
141
Exchange
NASDAQ
add Optinose  to watchlist

Keep an eye on Optinose

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is Optinose 's (OPTN) price per share?

The current price per share for Optinose (OPTN) is $0.42. The stock has seen a price change of $0.01 recently, indicating a 1.56% change. This reflects the stock's recent market performance and investor sentiment.
help

What is the 52-week high and low for Optinose (OPTN)?

For Optinose (OPTN), the 52-week high is $2.1, which is 394.12% from the current price. The 52-week low is $0.31, the current price is 37.99% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help

Is Optinose (OPTN) a growth stock?

Optinose (OPTN) has shown an average price growth of -4.97% over the past three years. It has received a score of 11 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Optinose as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help

What is Optinose (OPTN) stock price performance year to date (YTD)?

As of the latest data, Optinose (OPTN) has a year-to-date price change of -66%. Over the past month, the stock has experienced a price change of 7.59%. Over the last three months, the change has been -40.97%. Over the past six months, the figure is -61.01%. Looking at a longer horizon, the five-year price change stands at -95.68%.
help

Is Optinose (OPTN) a profitable company?

Optinose (OPTN) has a net income of -$35.48M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 87.84% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -10.04% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , although specific revenue growth data is currently not available. The gross profit is $62.35M. Operating income is noted at -$22.75M. Furthermore, the EBITDA is -$18.86M.
help

What is the market capitalization of Optinose (OPTN)?

Optinose (OPTN) has a market capitalization of $63.36M. The average daily trading volume is 0.43, indicating the stock's liquidity and investor engagement.

Take Your Investments to a Whole New Level